About Merlin Biotech
Merlin Biotech is a private company based in Doylestown, Pennsylvania, incorporated in 2022 in Delaware. It has reported $50,000 raised in one offering on Form D since August 2026. Its chief executive is Randall Hyer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 11, 2026 | $50,000fully sold | 2 | $25,000 | DebtRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Merlin Biotech's Form D filed Aug 11, 2026.
JB
Jay Bhatia
Director
NH
Nikhil Heble
Executive officer
Nick Spring
Business Strategy & Commercialization
Carol Brosgart
Director
Loren Danzis
Partner, Fox Rothschild LLP and director